Overview
Foundation Model Platform including REPRESS for microRNA binding and mRNA degradation prediction, plus complementary models for RNA processing and editing supporting therapeutic target identification and ASO, siRNA, and mRNA design.
Product and company
Foundation Model Platform is a verified product offering linked to the Brel Digital company profile for Deep Genomics.
Use cases
Foundation Model Platform including REPRESS for microRNA binding and mRNA degradation prediction, plus complementary models for RNA processing and editing supporting therapeutic target identification and ASO, siRNA, and mRNA design.
Target customer
Biopharmaceutical R&D teams, RNA therapeutics developers, and genomic medicine researchers designing precision therapies from sequence data.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Large Language Models, Machine Learning, Predictive Analytics.
Sources and references
- Official product / company source: https://www.deepgenomics.com/news/deep-genomics-expands-ai-foundation-model-platform-decoding-rna-biology/
- Supporting source: https://www.deepgenomics.com/team
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- Foundation Model Platform including REPRESS for microRNA binding and mRNA degradation prediction, plus complementary mode
- REPRESS for microRNA binding
- mRNA degradation prediction
- plus complementary models for RNA processing
- editing supporting therapeutic target identification
- and mRNA design
Extracted from the linked company product description already verified on Brel. No capabilities were invented.